🇺🇸 FDA

Company profile · Sponsor

Photonamic

Photonamic GmbH & Co. KG

E806348 · EMA pharma EU
Pipeline
2
Drugs
0
Patents
0

Quick answer

Photonamic (E806348) is a pharma company. headquartered in EU. listed on EMA. NovaPharmaNews links 2 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker E806348
Exchange EMA
Company type pharma
Headquarters EU

Pipeline (2)

Search pipeline →

  1. Gliolan 30 mg/ml powder for oral solution.

    Photonamic

    Colorectal Carcinoma

    phase 2 small molecule active

    1 trial

  2. Gliolan 30 mg/ml powder for oral solution.

    Photonamic

    Glioblastoma

    phase 2 small molecule active

    1 trial

Frequently asked questions

What is Photonamic?

Photonamic (E806348) is a pharma company. headquartered in EU. listed on EMA. NovaPharmaNews links 2 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does Photonamic sponsor?

We track 2 ClinicalTrials.gov-linked programs for Photonamic, including Gliolan 30 mg/ml powder for oral solution. and 1 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Photonamic company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.